Literature DB >> 9790988

Role of nitric oxide production through M2-cholinergic receptors in cultured rat ventricular myocytes.

S Yamamoto1, A Miyamoto, S Kawana, A Namiki, H Ohshika.   

Abstract

We previously reported that carbachol (CCh) caused the enhancement of NO production coinciding with negative chronotropy in cultured rat ventricular myocytes. In this study, we examined which subtype of muscarinic cholinergic receptor mediated these effects of CCh by measuring the NOx production with an HPLC-Griess reaction system and monitoring the beating with a Fotonic Sensor. The enhancement of NO production and negative chronotropy by 10(-4) M CCh stimulation were significantly inhibited by 10(-6) M atropine, 10(-6) M methoctramine, 3 x 10(-4) M L-NMMA, and 10(-5) M methylene blue. On the other hand, 10(-6) M pirenzepine and 10(-6) M HHSiD had no influence on the negative chronotropy by 10(-4) M CCh stimulation. Both 10(-6) M pirenzepine and 10(-6) M HHSiD suppressed the enhancement of NO production by 10(-4) M CCh stimulation slightly though not statistically. In addition, the m2 cholinergic receptor gene was expressed in our cell preparations, as demonstrated by reverse-transcriptase/PCR analysis. We concluded that M2-cholinergic receptor-mediated negative chronotropy may be due in part to activation of the NO-signaling pathway in cultured rat ventricular myocytes. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790988     DOI: 10.1006/bbrc.1998.9547

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Inhibition of neuronal M(2) muscarinic receptor function in the lungs by extracellular nitric oxide.

Authors:  L Golkar; K A Yarkony; A D Fryer
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Enhancement of nitric oxide production by methylecgonidine in cultured neonatal rat cardiomyocytes.

Authors:  Yinke Yang; Haisun Liao; Qingen Ke; Jingbo Cai; Yong-Fu Xiao; James P Morgan
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.